How this type of drug discovery offers cost and risk advantages over traditional forms of drug discovery.

The importance of the data quality offered by human challenge models in lab-base analysis.

The growing importance of AI in drug discovery, and how Poolbeg’s leading position should open up partnering opportunities with biopharma groups.